Limited data are available regarding the association of C7 and kallistatin with cancer; one prior study reported C7 gene polymorphisms in liver transplant recipients being linked to hepatocellular carcinoma recurrence after transplantation [30], while another study noted lower kallistatin levels in hepatocellular carcinoma patients compared with healthy controls [37]. The gene discussed is SERPINA4; the disease is hepatocellular carcinoma.